Randomized trial includes carbon footprint as an endpoint in clinical practice, suggesting a shift towards sustainability.
Including carbon footprint as an end point in randomized, controlled trials could help clinicians, regulators, and policymakers understand the environmental effects of medical interventions.
No takes yet. Share an insight, caveat, or question.
Nordberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: